Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGaming Realms Regulatory News (GMR)

Share Price Information for Gaming Realms (GMR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 36.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.60 (1.676%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 36.50
GMR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re: Suspension

2 Jul 2013 07:00

RNS Number : 3465I
Pursuit Dynamics PLC
02 July 2013
 



2 July 2013

Pursuit Dynamics PLC

("PDX" or the "Company')

Sale of Pursuit Marine Drive

and

Statement re: Suspension

 

Pursuit Dynamics (AIM: PDX) announces that it has entered into a conditional agreement to sell its UK subsidiary Pursuit Marine Drive Limited ("PMD") to Cellulac Limited ("Cellulac") in line with the Group's announced strategy of realising value from the sale of its intellectual property and reducing liabilities. The sale of PMD is deemed to be a disposal resulting in a fundamental change of business under AIM Rule 15 and is, therefore, conditional upon shareholder approval at a general meeting.

 

A deposit of £50,000 in cash has already been paid to PDX. An additional cash sum of £950,000 may become payable on 31 December 2013 or earlier, subject to certain milestones being met by Cellulac but as the achievement of these milestones is uncertain and they are all outside the control of PDX, the Directors of PDX cannot assess the likelihood of these milestones being achieved. The assets of PMD comprise PDX Reactor intellectual property, Ethanol Reactor Systems installed in the US and various plant and equipment. The transaction also includes obligations to use reasonable endeavours to procure the transfer of two EU funded projects in biofuels and algae.

 

In the year ended 30 September 2012, the PMD business generated turnover of approximately £0.7 million (including £0.4 million in relation to the food, beverage and brewing business, whose sale was announced on 1 May 2013) and a loss before tax of £22.7 million. The gross assets attributable to PMD are £1.96 million. The proceeds will be used for future opportunities to create value for shareholders.

 

Upon completion of the proposed transaction, following approval at the general meeting, the Board will have eliminated almost all of the liabilities associated with PDX.

 

Over recent months, alongside the disposal programme, the Directors have been evaluating potential acquisitions. The Board is now in advance-stage negotiations in relation to an acquisition which would constitute a reverse takeover for the purposes of the AIM Rules and would be conditional upon, inter alia, the publication of an admission document by the Company and the approval of the Company's shareholders at a general meeting.

 

In accordance with the AIM Rules, trading in the Company's ordinary shares will be suspended with effect from 7:30 a.m. today pending publication of an admission document by the Company or an announcement that the proposed acquisition is no longer proceeding.

The proposed acquisition also remains conditional on, inter alia, the satisfactory conclusion of the Company's due diligence, and is subject to the granting of a waiver of the obligation to make a general offer pursuant to Rule 9 of the City Code on Takeovers and Mergers.

 

Whilst the proposed acquisition is at an advanced stage, there can be no certainty that it will be concluded successfully. Should the proposed disposal proceed and the proposed acquisition not conclude, the Company will be treated as an investing company under the AIM Rules and will send a circular to shareholders setting out an investing policy to be approved by shareholders at a general meeting. In this instance, the Company will then have to make an acquisition or acquisitions which constitute a reverse takeover under AIM Rule 14 or otherwise implement the investing policy approved at the general meeting within twelve months of becoming an investing company, failing which trading in the Company's shares would be suspended. If a company has been suspended from trading for six months the Exchange will cancel the admission of the ordinary shares.

 

A further announcement will be made in due course.

 

 

For further information, please contact:

PDX

+44 (0)1480 422 050

Dr Bernard Bulkin, Chairman

 

 

Cenkos Securities plc

 

+44 (0)20 7397 8900

Ian Soanes

Max Hartley

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRLLFEDDSILIIV
Date   Source Headline
2nd Apr 20247:01 amRNSInvestor Presentation
2nd Apr 20247:00 amRNSAnnual Results 2023
27th Mar 20244:05 pmRNSTotal Voting Rights and Share Capital
5th Feb 20247:00 amRNSPre-Close Trading Update
30th Jan 20244:00 pmRNSBlock Listing Six Monthly Return
30th Jan 20244:00 pmRNSTotal Voting Rights and Share Capital
30th Nov 20237:00 amRNSTotal Voting Rights and Share Capital
28th Sep 20237:00 amRNSInvestor Presentation
12th Sep 20237:00 amRNSInterim Results
14th Aug 20237:00 amRNSDirector/PDMR Shareholding
7th Aug 20237:00 amRNSDirector/PDMR Shareholding
3rd Aug 20234:59 pmRNSDirector/PDMR Shareholding
28th Jul 20232:00 pmRNSTotal Voting Rights and Share Capital
28th Jul 20232:00 pmRNSBlock Listing Six Monthly Return
27th Jul 20237:00 amRNSPre-Close Trading Update
30th Jun 20233:02 pmRNSTotal Voting Rights and Share Capital
31st May 202312:35 pmRNSResult of AGM
3rd Apr 20237:00 amRNSAnnual Results 2022
1st Feb 20237:00 amRNSPre-Close Trading Update and Board Changes
30th Jan 20231:05 pmRNSBLOCK LISTING SIX MONTHLY RETURN
24th Jan 20237:00 amRNSGaming Realms to Introduce Tetris® Slingo®
20th Jan 20234:40 pmRNSSecond Price Monitoring Extn
20th Jan 20234:35 pmRNSPrice Monitoring Extension
14th Dec 20227:00 amRNSAppointment of Joint Broker
12th Dec 20227:00 amRNSRepayment of Loan
25th Nov 20224:40 pmRNSSecond Price Monitoring Extn
25th Nov 20224:35 pmRNSPrice Monitoring Extension
1st Nov 20227:00 amRNSBoard Appointment
25th Oct 20227:00 amRNSGaming Realms launches content in Connecticut
14th Oct 20224:40 pmRNSSecond Price Monitoring Extn
14th Oct 20224:36 pmRNSPrice Monitoring Extension
20th Sep 20227:00 amRNSInterim Results
16th Sep 20227:00 amRNSRetail Investor Conference Call
22nd Aug 20224:41 pmRNSSecond Price Monitoring Extn
22nd Aug 20224:35 pmRNSPrice Monitoring Extension
10th Aug 20227:00 amRNSNotice of Results
28th Jul 20222:14 pmRNSBLOCK LISTING SIX MONTHLY RETURN
15th Jul 20224:41 pmRNSSecond Price Monitoring Extn
15th Jul 20224:35 pmRNSPrice Monitoring Extension
12th Jul 20223:45 pmRNSDirector/PDMR Shareholding
11th Jul 20224:35 pmRNSPrice Monitoring Extension
23rd Jun 202212:40 pmRNSDirector/PDMR Shareholding
21st Jun 20227:00 amRNSGaming Realms granted Licence in Connecticut
8th Jun 202212:03 pmRNSResult of AGM
12th May 20224:41 pmRNSSecond Price Monitoring Extn
12th May 20224:35 pmRNSPrice Monitoring Extension
11th May 20227:00 amRNSDirector/PDMR Shareholding
26th Apr 20227:00 amRNSAnnual Results 2021
6th Apr 20227:00 amRNSGaming Realms launches content in Ontario
31st Mar 20222:25 pmRNSTotal Voting Rights and Share Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.